Search

Search Constraints

You searched for: Author/Creator Zanetta, Sylvie

Search Results

1. A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial. (November 2021)

2. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. Issue 4 (April 2021)

3. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Issue 2 (February 2022)

4. Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales). (November 2021)

5. Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study. (2nd September 2018)

6. Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study. Issue 1 (1st January 2020)

7. Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study. Issue 1 (20th May 2020)

8. Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study. Issue 1 (20th May 2020)

9. Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study. (May 2021)

10. Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab. (24th October 2016)